ABT

Abbott Laboratories
$88.95
-0.01 (-0.01%)
Mkt Cap 155.78B
Volume 7,872,633
52W Range 81.97-137.49
Sector Healthcare
Beta 0.61
EPS (TTM) 3.60
P/E Ratio 24.84
Revenue (TTM) 45.13B
Rev Growth (5Y) +5.1%
EPS Growth (5Y) +8.2%
AlphaVal · Fair Value
What we estimate one share is worth
$78.00
Overvalued weak signal
14.7% above fair value
Modeled from cash flows & growth.
AlphaQuality · Grade
How strong & durable the business is
B-
Stable Earnings Power
64.8 / 100 composite
Steady, predictable earnings power — graded A–F vs. similar companies.

Company Description

Track Record

Showing latest 4 periods • Swipe for more
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue 44.33B 41.95B 40.11B 43.65B 43.08B 34.61B 31.90B 30.58B 27.39B 20.85B 20.41B 20.25B
Net Income 6.52B 13.40B 5.72B 6.93B 7.07B 4.50B 3.69B 2.37B 477.00M 1.40B 4.42B 2.28B
EPS 3.74 7.67 3.30 3.94 3.97 2.52 2.07 1.35 0.27 0.95 3.00 1.51
Free Cash Flow 7.39B 6.35B 5.06B 7.80B 8.65B 5.72B 4.50B 4.91B 4.43B 2.08B 1.86B 2.60B
FCF / Share 4.23 3.67 2.92 4.45 4.87 3.23 2.54 2.79 2.54 1.41 1.26 1.72
Operating CF 9.57B 8.56B 7.26B 9.58B 10.53B 7.90B 6.14B 6.30B 5.57B 3.20B 2.97B 3.67B
Total Assets 86.71B 81.41B 73.21B 74.44B 75.20B 72.55B 67.89B 67.17B 76.25B 55.01B 44.00B 43.79B
Total Debt 15.07B 15.28B 15.87B 17.95B 19.25B 19.89B 19.10B 19.57B 27.92B 22.01B 9.00B 7.83B
Cash & Equiv 8.52B 7.62B 6.90B 9.88B 9.80B 6.84B 3.86B 3.84B 9.41B 18.62B 5.00B 4.06B
Book Value 52.13B 47.66B 38.60B 36.69B 35.80B 32.78B 31.09B 30.52B 30.90B 20.54B 21.21B 21.53B
Return on Equity 0.13 0.28 0.15 0.19 0.20 0.14 0.12 0.08 0.02 0.07 0.21 0.11
ABT News
Abbott's Q2 Earnings on Deck: How Should You Play the Stock Now?
Jul 14, 2026 06:35 AM · zacks.com
Abbott Labs Vs. Pfizer: Which Discounted Healthcare Titan Screens as the Bigger Value Trap?
Jul 13, 2026 12:47 PM · 247wallst.com
Unlocking Q2 Potential of Abbott (ABT): Exploring Wall Street Estimates for Key Metrics
Jul 13, 2026 06:15 AM · zacks.com
Abbott Labs Vs. Danaher: Abbott's Everyday Products Beat Danaher's Slumping Biotech Equipment
Jul 10, 2026 10:18 AM · 247wallst.com
Brokers Suggest Investing in Abbott (ABT): Read This Before Placing a Bet
Jul 09, 2026 06:31 AM · zacks.com
Abbott Labs vs. Glaukos: Which Healthcare Stock Is a Better Buy in 2026?
Jul 08, 2026 01:03 PM · fool.com
Eli Lilly and Novo Nordisk Are Fine -- but These 2 Stocks Could Be an Even Better Way to Invest in the GLP-1 Boom
Jul 07, 2026 01:30 PM · fool.com
5 Dividend Kings Long-Term Investors Should Own for the Next 20 Years
Jul 07, 2026 10:00 AM · fool.com
Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It
Jul 06, 2026 06:01 AM · zacks.com
3 Stocks to Buy and Hold: The Long-Term Play for Your Portfolio
Jul 06, 2026 04:30 AM · fool.com